|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
| Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00005216 |
Purpose
To determine if silent myocardial ischemia was associated with an increased risk of cardiac mortality and morbidity during a one to three year follow-up in patients with coronary heart disease.
| Condition |
|
Cardiovascular Diseases Coronary Disease Myocardial Ischemia Heart Diseases Myocardial Infarction Angina, Unstable Arrhythmia |
| Genetics Home Reference related topics: | Brugada syndrome short QT syndrome |
| MedlinePlus related topics: | Angina Arrhythmia Heart Attack Heart Diseases |
| Study Type: | Observational |
| Study Design: | Natural History |
| Study Start Date: | April 1988 |
| Estimated Study Completion Date: | December 1994 |
![]() |
Show Detailed Description |
Eligibility
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
No eligibility criteria
Contacts and Locations
More Information
| Study ID Numbers: | 1095 |
| First Received: | May 25, 2000 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00005216 |
| Health Authority: | United States: Federal Government |
|
|
|